Radiopharma’s precision promise runs into toxicity problems, China puts new guardrails around its biotech innovation engine, and Grail’s Galleri heads to an FDA advisory panel.

This Readout was partially produced at a sun-splashed kiddie pool party in SoCal. Each matriarch toenail is perfectly shellacked.